 |
Williams III, Robert O. (Bill), Ph.D. |
Williams' research has focused on the formulation development, optimization, and delivery of small organic compounds, peptides, and proteins by a variety of technologies, including depot drug delivery, oral drug delivery and pulmonary/nasal drug delivery. |
 |
Croyle, Maria A., Ph.D. |
Work in Dr. Croyle's lab focuses on the development of novel methods for rapid immunization against dangerous pathogens like Ebola. Additional projects focus on the long-term physiological effects of virus infection with respect to the immune response and drug metabolism. As these progress toward clinical application, our work also addresses the need for novel formulations to enhance both the physical stability and potency of virus-based preparations as well as methods by which to deliver them through the mucosal route. |
 |
Dolusio, James T., Ph.D. |
Doluisio is the Hoechst-Roussel Centennial Professor Emeritus of Pharmacy . He has written more than 90 papers on bioequivalency and drug absorption, biopharmaceutics, pharmacokinetics, physical pharmacy, pharmacy education and various pharmacy issues for national and international journals, textbooks and conferences. |
 |
McConville, Jason, Ph.D. |
McConville's primary research interests are advanced formulation design and pre-clinical analysis, nanotechnology: enhancing dissolution rates and bioavailability, in vitro and in vivo correlations, and pulmonary delivery of active pharmaceutical ingredients, for local or systemic therapy. |
 |
McGinity, James W., Ph.D. |
The current use of high speed machinery in the pharmaceutical industry dictates that the pharmaceutical scientist must be cognizant of the physical and chemical properties of drugs and other adjuvants used in pharmaceutical dosage forms. McGinity's research has focused on controlled release technologies and polymeric drug delivery systems. |
 |
Smyth, Hugh D., Ph.D. |
Work in Dr. Smyth's lab focuses on the development of novel methods for drug delivery to the airways in health and disease. For example, his group investigates unique microparticle aerosols for controlled release, transformative inhaler and device designs, nanoparticle enhancers for drug transport, inhaled vaccines, and other areas of respiratory drug delivery. Translation of these technologies to the clinic is the long-term goal of the lab and is supported by developing a mechanistic understanding of the complex physical and biological systems. |
 |
Stavchansky, Salomon A., Ph.D. |
The primary mission of Stavchansky's laboratories is to apply the principles of biopharmaceutics, pharmacokinetics, and drug metabolism to evaluate and design drug delivery systems to ensure the safety and efficacy of drug products. |
 |
Walkow, Janet C., Ph.D. |
The Drug Dynamics Institute is a multi-disciplinary research center where scientists, educators, businesses and regulatory agencies collaborate in finding solutions to a wide range of biomedical, pharmaceutical and public health issues. |
Division Information
Mailing Address:
Pharmaceutics Division
College of Pharmacy
The University of Texas
at Austin
1 University Station,
A1900
Austin, TX
78712-01200
USA
Email Address: pharmacy
@www.utexas.edu
Phone:
1-512-471-7182
Sandra Schilling, a graduate student in the lab of Dr. James McGinity, professor of pharmaceutics, was honored for her poster presentation at the 17th International Symposium on Microencapsulation.
> Read more about Schilling's award.
Dr. Jason McConville and Javier Morales have taken a first place award at this year's ExcipientFest Americas meeting in Puerto Rico.
